VEGF's Role in Breast Cancer Prognosis
Author Information
Author(s): Coradini D, Boracchi P, Daidone M Grazia, Pellizzaro C, Miodini P, Ammatuna M, Tomasic G, Biganzoli E
Primary Institution: Istituto Nazionale per lo Studio e la Cura dei Tumori, Università degli Studi di Milano, Milan, Italy
Hypothesis
The study evaluates the prognostic contribution of intratumour VEGF to the Nottingham prognostic index in node-negative breast cancer.
Conclusion
VEGF provides an additional prognostic contribution to the Nottingham prognostic index, especially in estrogen receptor-poor tumors.
Supporting Evidence
- VEGF is the most important factor in tumor-induced angiogenesis.
- VEGF's contribution to NPI was evaluated while accounting for steroid receptors and cell proliferation.
Takeaway
This study found that a substance called VEGF can help doctors understand how serious breast cancer might be, especially in certain types of tumors.
Methodology
Flexible modelling was used to evaluate the prognostic contribution of VEGF in breast cancer patients.
Participant Demographics
N-primary breast cancer patients, specifically those who are node-negative.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website